coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Swanley & Rural PCN, Sevenoaks · Health Inequalities Profile

    PCN U40722 · NHS Kent and Medway Integrated Care Board · 2 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    37,220

    Registered population

    57.4% aged 18–64

    22.1%

    Aged 65+

    ICB 19.9% · England 17.9%

    10.3%

    Ethnic minority (non-White)

    3.3% Asian · England 9.6%

    15.9%

    In IMD quintile 1

    ICB 17.1% · England 21.0%

    ~5,796

    Core20 residents (est.)

    Resident basis; registered basis ~5,914 · see page 3

    7,474

    Hypertension register

    +29.17% in 3 yrs · England +5.60%

    360

    SMI register

    39.5% of Sevenoaks'

    759

    COPD register

    Reviews -5.71% in 3 yrs

    Forecast to 2030

    12,893

    Hypertension patients, 2030

    +5,419 on today

    55.6%

    QRISK ≥20% on statins, 2030

    -5.44pp over 3 yrs

    6.0%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    66.9%
    Blood pressure control trails rapid register growth.

    Hypertension control is 66.9% (England 70.3%) despite +29.2% register growth, while QRISK lipid therapy fell 7.7%, which may reflect review backlogs.

    53.2%
    Asthma and COPD annual reviews trail England.

    Asthma reviews fell 10.1% to 53.2% (England 65.7%) and COPD reviews are 62.2% (England 76.4%), which could reflect recall capacity pressures.

    +88.5%
    Heart failure and mental health checks rose.

    Heart failure reviews rose +88.5% to 86.3% (England 78.5%) and SMI blood pressure checks rose +22.6 pp over 2023 to 2025.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older adults comprise 22.1% of patients, exceeding borough, ICB, and England benchmarks

    Across 37,220 registered patients, 22.1% (8,225) are aged 65+, above Sevenoaks (19.7%), NHS Kent and Medway ICB (19.9%), and England (17.9%). Children aged 0–17 represent 20.5% (7,642; Sevenoaks 21.7%, ICB 20.7%, England 19.6%). Practice scale is uneven: River Darent Medical Group has 12,258 patients (25.2% aged 65+), while Swanley Medical Practice has 24,962 (20.6% aged 65+). Census usual-resident data show 89.7% White (Sevenoaks 92.1%, ICB 88.6%, England 81.1%). Unverified ONS projections indicate 1.8% list growth to 2030 (Sevenoaks 2.9%, ICB 6.0%, England 2.3%). A higher older-adult proportion across both practices could indicate elevated frailty demand, testable through practice clinical register.

    Age profile

    0–1720.5%
    18–6457.4%
    65+22.1%

    65+: ICB 19.9%, England 17.9%

    Ethnicity

    White89.7%
    Black3.8%
    Asian3.3%
    Mixed2.3%
    Other0.9%

    Older people · falls rows are Sevenoaks local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Sevenoaks LA)2,2622,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)81.8%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)57.7%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Sevenoaks LA)1,1549819552024/25
    Falls deaths, all ages, per 100,000 (Sevenoaks LA)15.514.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is 15.9% across the PCN and concentrates in Swanley Medical Practice

    The PCN Core20 cohort is 15.9%, above Sevenoaks (4.4%) but below NHS Kent and Medway ICB (17.1%) and England (21.0%), with weighted practice shares reconciling at 15.9%. Deprivation divides sharply across practices: Swanley Medical Practice records a 22.8% Core20 share (an estimated 5,701 patients), whereas River Darent Medical Group records 1.7% (an estimated 213 patients), creating a 21.1 pp spread. Concentration of estimated Core20 patients in Swanley Medical Practice indicates uneven deprivation demand, which practice-level clinical audits can test.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Swanley Medical22.8% · 5,701 patients
    River Darent1.7% · 213 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    360

    SMI register

    0.96% recorded prevalence

    177

    Learning disability register

    0.47% recorded prevalence

    7

    Care homes, 373 beds

    In the PCN catchment

    8.7%

    Provide unpaid care

    Sevenoaks, Census 2021

    Registers record 177 learning disability patients (0.5%; Sevenoaks 0.4%, ICB 0.6%, England 0.6%) and 360 severe mental illness patients (1.0%; Sevenoaks 0.8%, ICB 0.9%, England 1.0%). Catchment services include 7 care homes (373 beds) and 0.8% Gypsy or Irish Traveller residents (Sevenoaks 0.4%, ICB 0.3%, England 0.1%). Higher Gypsy or Irish Traveller presence may reflect distinct community access needs, testable via practice registration audits.

    Severe mental illness: physical health checks

    SMI blood pressure checks reached 81.5% (Sevenoaks 85.2%, England 83.4%), rising +22.6 pp over 2023 to 2025 (England +4.4 pp). Smoking cessation support offered to patients with certain conditions was 88.7% (England 94.2%; Swanley Medical Practice 87.0%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    7,474

    Hypertension register

    +29.17%

    Register growth, 3 yrs

    Sevenoaks +14.96% · England +5.60%

    +1.93pp

    BP control, under 80

    ≤140/90 · +4.52pp aged 80+

    +5,419

    More patients by 2030

    Forecast 12,893 (33.41%)

    Hypertension case-finding and control

    Hypertension prevalence is 20.0% (7,474 patients), higher than Sevenoaks (16.6%), NHS Kent and Medway ICB (16.2%), and England (15.2%), having grown +29.2% over 2023 to 2025 (England +5.6%). However, patients treated to target reach 66.9%, trailing England's 70.3%. In patients aged under 80, control to <= 140/90 mmHg is 62.8% (England 67.8%), with Swanley Medical Practice at 60.9% and River Darent Medical Group at 66.4%. In those aged 80 and over, control is 76.8% (England 81.2%). Crude prevalence does not reflect age-adjusted need, and denominators include personalised care adjustments. Lower control rates in patients aged under 80 may reflect review backlogs or titration delays, unverified locally and testable by recall audit.

    Lipids and statins

    Patients with QRISK ≥ 20% receiving lipid-lowering therapy stand at 65.2% (England 63.6%, Sevenoaks 60.3%), but this fell 7.7% over 2023 to 2025 (England +6.2%). Recent contraction could reflect recall gaps, unverified locally and testable by high-risk patient search review.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202663,640£1.90£1.90£1.86£120,916
    Cardiovascular (all), 202584,074£4.77£3.57£3.33£401,033

    In 2026, lipid-regulating drugs cost £1.90 per item across 63,640 items, compared to £1.86 in England, £1.68 in Sevenoaks, and £1.90 in NHS Kent and Medway ICB. This represents £2,546 more than at England's unit cost.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −10.13%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +3.30%

    Asthma prevalence, PCN 3-yr % change

    Asthma reviews fell 10.1% over 2023 to 2025 (England +4.4%) to 53.2% (England 65.7%, Sevenoaks 58.8%), leaving about 950 patients unreviewed across a register of 2,023. COPD reviews fell 5.7% (England +2.8%) to 62.2% (England 76.4%, Sevenoaks 68.5%) on a register of 759 patients, which contracted 7.1% (England +2.6%). COPD review coverage is 58.6% at Swanley Medical Practice and 70.3% at River Darent Medical Group. Falling reviews could reflect recall capacity constraints, unverified locally and testable by search review.

    Cancer register and children's immunisation

    The cancer register records 1,814 patients (4.9% vs England 3.8%). In Q1 2025/26, MMR1 coverage at 24 months was 87.0% (below the 95.0% target by 8 pp; England 88.3%), and age-5 4-in-1 booster coverage was 87.2% (below target by 7.8 pp; England 80.9%). Age-5 MMR1 (94.2%) exceeded MMR2 (90.7%) by a 3.5 pp dose difference. Dose drop-off could reflect call-recall gaps, unverified locally and testable by list audit.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months91.6%

    England 91.0%

    6-in-1 complete primary course at 24 months91.3%

    England 92.2%

    MMR dose 1 at 24 months87.0%

    England 88.3%

    MMR dose 2 at age 590.7%

    England 82.8%

    4-in-1 pre-school booster at age 587.2%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Kent and Medway ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,630

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Kent and Medway ICBEnglandNo usable stageStaged cancers
    Breast82.1%85.4%23%1,509
    Prostate54.4%53.2%37%1,435
    Lung29.4%33.8%21%1,109
    Bowel48.2%47.0%29%1,013
    Skin cancer87.5%87.8%23%562

    Across NHS Kent and Medway ICB in 2022, 55.6% of cancers were diagnosed at stage 1 or 2 (4,661 of 8,384 staged cancers), in line with England (55.3%) but below the 75.0% national ambition by 2028 by 19.4 pp. Known-stage data covered 63.6% of registered cancers (8,384 of 13,189; England 67.0%). These figures describe the wider system rather than PCN performance. Locally, PCN cervical screening coverage aged 25-49 is 70.9% (Sevenoaks 73.4%, England 66.8%) and breast screening coverage is 69.4% (Sevenoaks 73.5%). Lower screening uptake than the borough average may delay early detection, making primary care call-recall coordination the principal operational priority.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026 (provisional), Dartford and Gravesham NHS Trust met the cancer 62-day referral to treatment standard for 63.6% of pathways (65.5 of 103), trailing the 85.0% standard by 21.4 pp, below NHS Kent and Medway Integrated Care Board (75.9%), King's College Hospital NHS Foundation Trust (70.1%) and England (71.2%). Conversely, the trust achieved 78.1% on the 28-day faster diagnosis standard (standard 75.0%) and 97.5% on the 31-day standard (standard 96.0%). Diagnostic waits of 6+ weeks across all tests were 8.4% (England 23.1%). System treatment delays reinforce the need for robust primary care referral safety netting and fast-track tracking.

    Pathways within standard (%)Dartford and GraveshamKing's CollegeKent and Medway ICBEngland
    28-day faster diagnosis (75%)78.1480.6876.7879.32
    31-day treatment (96%)97.4896.6895.8492.50
    62-day referral to treatment (85%)63.5970.1575.9371.16
    Diagnostic waits over 6 weeks (%)Dartford and GraveshamKent HealthKing's CollegeEngland
    MRI0.36—21.2221.40
    CT2.08—22.609.92
    Echocardiography3.90—14.3928.48
    Colonoscopy0.40—41.8130.83
    Gastroscopy0.00—35.9829.02
    All 15 DM01 tests8.3727.4919.1523.14
    Community services activityKent residentsKent and Medway ICB
    Care contacts210,170254,055
    Referrals59,36068,085
    Patients with a contact60,60572,060

    Community services (residents of Kent), Jun 2026 (provisional). In June 2026 (provisional), Kent residents accounted for 265,905 community care activities and 210,170 contacts across 60,605 patients, with 59,360 referrals. Across NHS Kent and Medway Integrated Care Board, activity reached 297,595 activities and 254,055 contacts across 72,060 patients. Contacts with adults aged 65+ represented 65.8% of Kent residents' contacts (138,250 of 210,170). Substantial community contact volume among older residents highlights an active pathway for local multidisciplinary support.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Overall patient experience varies by 13.2 pp while phone access trails England

    In 2025/26, QOF clinical achievement was 98.5% at Swanley Medical Practice and 98.4% at River Darent Medical Group (England 97.1%). For vaccination and immunisation, Swanley Medical Practice achieved 38.3% and River Darent Medical Group achieved 32.5%, trailing England (55.2%) across a 5.8 pp spread. Shared vaccination shortfalls indicate an immunisation delivery gap despite high clinical points.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Swanley Medical11222.835.9%73.6%73.4%
    River Darent1081.741.5%73.1%60.2%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNSevenoaksAssetPCNSevenoaks
    Care homes (catchment)7 (373 beds)n/aSchools (catchment)54n/a
    Children's centres35Places of worship3386
    Libraries311Day centres (VCS)811
    Children and young people (VCS)12Carers support groups (VCS)n/a3
    Primary schools (LA maintained)824Primary academies712
    Special schoolsn/a1

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Hypertension control and lipid review

    Across 7,474 hypertensive patients (20.0%), BP control is 66.9% (England 70.3%; under 80s 62.8% vs 67.8%, with Swanley Medical Practice at 60.9% and River Darent Medical Group at 66.4%). QRISK ≥ 20% lipid therapy (65.2%) fell 7.7% (England +6.2%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Asthma and COPD annual review recall

    Asthma reviews fell 10.1% to 53.2% (England 65.7%, +4.4%), leaving 947 unreviewed of 2,023 patients. COPD reviews fell 5.7% to 62.2% across 759 patients (England 76.4%, +2.8%; Swanley Medical Practice 58.6%, River Darent Medical Group 70.3%). Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Dementia and learning disability register audit

    The dementia register (347 patients, 0.9%) fell 5.6% over 2023 to 2025 (England +6.0%; gap range -56 to +15). Learning disability prevalence is 0.5% (177 patients vs England 0.6%; gap range -27 to +42). Low cost, quick to run.

    Evidence base: dementia diagnosis rates lag in deprived and minority ethnic populations and in care homes; the register is the cohort for diagnosis-rate improvement and the annual dementia review, and diagnosis and post-diagnostic support delay care-home entry.

    Policy anchor: national dementia diagnosis-rate ambition of 66.7%; 95% of people with complex needs to have an agreed care plan by 2027.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Frailty and complex care planning (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Differentiated Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Condition smoking cessation audit (p4)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension recall and titration (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Childhood immunisation recall overhaul (p6)MMR dose 1 coverage at 24 months10YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice telephony and triage review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Hypertension control and lipid review (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients treated to targetCore20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 2 · Asthma and COPD annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · COPD registerCore20PLUS5 respiratoryPCN & Practice
    Option 3 · Dementia and learning disability register audit (p12)Dementia register · Dementia: QOF prevalence · Learning disability register66.7% diagnosis ambition · 95% care plan 2027 · 75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15